Department of Health and Human Services January 4, 2018 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2017-28497
Type: Notice
Date: 2018-01-04
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected; and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Proposed Information Collection Activity; Comment Request
Document Number: 2017-28445
Type: Notice
Date: 2018-01-04
Agency: Department of Health and Human Services, Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Document Number: 2017-28443
Type: Notice
Date: 2018-01-04
Agency: Department of Health and Human Services, Administration for Children and Families
Good Abbreviated New Drug Application Submission Practices; Draft Guidance for Industry; Availability
Document Number: 2017-28435
Type: Notice
Date: 2018-01-04
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Good ANDA Submission Practices.'' This guidance is intended to assist applicants preparing to submit to FDA abbreviated new drug applications (ANDAs). This draft guidance highlights common, recurring deficiencies that may lead to a delay in the approval of an ANDA. It also makes recommendations to applicants on how to avoid these deficiencies with the goal of minimizing the number of review cycles necessary for approval.
Submission for OMB Review; Comment Request
Document Number: 2017-28432
Type: Notice
Date: 2018-01-04
Agency: Department of Health and Human Services, Administration for Children and Families
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.